HAWRYLUK MATTHEW (See Remarks) sold 2.9% of their position (9.26K shares) of GRITSTONE BIO, INC. on the open market
Open‑market sale worth $6.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/17/2024ACC: 0001415889-24-013654
Officer· See Remarks
Since Sep 2018
+189.89K
Net shares
Net buyer
$6.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
199.15K acquired · 9.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+19.15K
Price / share
—
Trade value
—
% of position
6.3%
5/15/2024
304.04K→323.19K
Common Stock
Direct
Shares
−9.26K
Price / share
$0.75
Trade value
$6.93K
% of position
2.9%
5/16/2024
323.19K→313.93K
Total
Net shares
+9.89K
Net value
-$6.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2024 | A · Award | +19.15K | — | — | 6.3% | 304.04K | 323.19K |
| Common Stock Direct | 5/16/2024 | S · Sale | −9.26K | $0.75 | $6.93K | 2.9% | 323.19K | 313.93K |
| Total | +9.89K | -$6.93K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
180K shares
Shares
+180K
Strike price
0.75
Held after
180K
Exercisable
—
5/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock180K shares | 5/15/2024 | A · Award | +180K | 0.75 | — | 180K |